Regenerative Scaffold Platform for Accelerated Tissue Growth and Repair (Scaffold for Tissue Growth and Repair, Tech ID: 12‑012)
This is a bioengineered scaffold designed to support tissue regeneration and functional repair by mimicking the structural and mechanical characteristics of native extracellular matrices. The scaffold provides a three‑dimensional framework that promotes cell attachment, proliferation, and differentiation while maintaining mechanical integrity during healing. Its architecture and material composition can be tuned for specific tissue applications, enabling use across both soft and load‑bearing tissues. The platform is compatible with cells, growth factors, and biologics, making it adaptable to a wide range of regenerative strategies.
Industry Pain Point: Conventional tissue scaffolds often lack sufficient mechanical strength or bioactivity, leading to poor integration, delayed healing, or implant failure.
NJIT Solution: This scaffold delivers a mechanically robust, biomimetic structure that enhances cellular response and tissue integration, improving regenerative outcomes.
Key Features & Advantages
- Biomimetic, tunable scaffold architecture
- Enhanced cell attachment and tissue integration
- Improved mechanical stability versus standard polymer scaffolds
- Applicable across multiple tissue types
Development Stage: TRL 4–5 – Laboratory and preclinical validation completed.
Target Markets
- Regenerative medicine
- Orthopedic and soft‑tissue repair
- Biomedical implants
Market Opportunity
- Global regenerative medicine market (2026): ~$45B
- CAGR: ~15–18%
- Projected market size (2035): >$110B
Commercial & IP Details
- Patent Status: Issued (US9746026B2 & US10420856B2)
- Patent Link:
Inventors: Treena Arinzeh, George Collins, Yee‑Shuan Lee